Delhi, September 2022: Akums Drugs & Pharmaceuticals Ltd., the leading contract manufacturing pharmaceutical company in India, has recently forged a prestigious and Exclusive collaboration with LC Ingredients to procure the raw material, manufacture, innovate & sell finished products containing Cynatine to all Indian big pharma and nutraceutical companies for the benefit of consumers. This move is another affirmation of Akums’ commitment to innovation and customer centric approach, since they identified a gap in the supplements market and bridged it as promptly as possible.
Deficiency of the fibrous protein called keratin in hair and nails results in increase in hair loss, thin and grey hair, as well as easily breakable and discolored fingernails. Conversely, lack of keratin in the skin makes it more prone to wrinkles, sagging, and dullness. Keratin, in its original form, is insoluble and non-absorbable by the body, hence cannot be consumed by humans. However, Cynatine’s high bioavailability makes it capable of delivering keratin peptides to the body and can be consumed by humans, with no fear of toxicity associated with it. This is a revolutionary step-up in the healthcare and supplements segment, and Akums will write the Indian chapter of Cynatine’s story.
Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain says, “In the erstwhile market, there were no healthcare supplements other than Biotin and regular hair, nail and skin (HNS) multivitamins for controlling hair fall and other related issues, but necessarily 100 percent effective. We identified this gap and when we found out about Cynatine, the only soluble source of keratin known, we connected with the innovator company LC ingredients with the aim to get exclusive rights so that we may introduce this revolutionary healthcare supplement in India. This collaborative effort will bridge the current availability gap for keratin soluble supplements. We are happy to announce that we will be the first and sole sellers of Cynatine in the Indian market. At Akums, we are glad to have yet added another ‘first’ to our laurels.”
Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sandeep Jain says, “Even though Cynatine is a soluble form of Keratin, it has not yet been listed with the regulatory authority FSSAI; means that no pharmaceutical company in India is permitted to produce it. This makes Akums, the only company in India with exclusive rights to sell this supplement. We have already conducted our own clinical trials on the Indian population and classified the supplement within the normal foods category. Cynatine reduces hair loss, boosts hair strength, and enhances hair's radiance and shine. It helps to promote firmness and elasticity in skin, minimizes fine lines and wrinkles, and improves strength by binding to the nail. And we are extremely excited to market it so that the Indian consumers may benefit from using it too.”
About Akums- Akums Drugs & Pharmaceuticals Ltd. is the largest contract manufacturing pharmaceutical company of India, manufacturing more than 12% of India’s consumption. The organization deals in the manufacturing and export of formulations in a wide spectrum of dosage forms & therapeutic segments. The company is currently supplying to almost all Indian and multinational pharmaceutical companies across the globe and is the 67th largest employer of the country.
Company :-Teamwork Communication Group
User :- Pragati Jain
Mobile:- +91 9319361024